CClinicalTrials.gg
CompletedNCT01122849Updated Apr 9, 2018Results posted

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

A Phase 2 interventional study of Prototype Nasal Dilator and Marketed Nasal Strip in Sleep Disorders and Congestion, Nasal, sponsored by GlaxoSmithKline. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-04-09.

Sponsored by GlaxoSmithKline · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this exploratory study is to evaluate the subjective measures of congestion and sleep quality in subjects who suffer from chronic nasal congestion and report trouble with their sleep.

02

Conditions studied

  • Sleep Disorders
  • Congestion, Nasal

Browse trials for

Keywords

  • trouble with sleep
  • night time nasal congestion
03

In context

Sleep Wake Disorders

788 studies on the registry are indexed under Sleep Wake Disorders; 186 are open to participants now.

This study's enrollment of 61 is close to the median of 62 across 548 interventional studies indexed under Sleep Wake Disorders.

Browse Sleep Wake Disorders studies →

Lead sponsor

GlaxoSmithKline is the lead sponsor of 3,562 studies on the registry; 117 are open to participants now.

Of its 258 completed or terminated interventional studies of FDA-regulated products, 232 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Subjects with leptorrhine noses
  • Subjects suffering from chronic nocturnal nasal congestion and report trouble with sleep
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    Prototype Nasal Dilator

    Prototype Nasal Dilator

    Device: Prototype Nasal Dilator

  • Active comparator
    Marketed Nasal Strip

    Marketed Nasal Strip

    Device: Marketed Nasal Strip

  • Placebo comparator
    Placebo Nasal Strip

    Placebo

    Device: Placebo Nasal Strip

Interventions

  • DevicePrototype Nasal Dilator

    Prototype nasal dilator AB2R11

  • DeviceMarketed Nasal Strip

    Breathe Right Nasal Strip- Clear small/medium

  • DevicePlacebo Nasal Strip

    Placebo strip

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7

    The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

    Time frame: At Baseline and Day 7

  2. Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14

    Participant were asked questions related to their sleep using PIRS questionnaire. The PIRS questionnaire had 3 sections. Section A (Q1 to Q12), Section B (Q13 to Q16) and Section C (Q17 to Q20). Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B questions 13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Questions 15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

    Time frame: At Baseline and Day 14

  3. Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7

    Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers (such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

    Time frame: At Baseline and Day 7

  4. Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14

    Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

    Time frame: At Baseline and Day 14

  5. Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7

    Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lower CQ7 scores reflect better nasal patency.

    Time frame: At Baseline and Day 7

  6. Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14

    Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lowe CQ7 scores reflect better nasal patency.

    Time frame: At Baseline and Day 14

  7. Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7

    Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

    Time frame: Day 7

  8. Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14

    Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

    Time frame: Day 14

  9. Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7

    Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

    Time frame: Day 7

  10. Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.

    Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0=extremely difficult to breathe and 100=extremely easy

    Time frame: Day 14

  11. Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7

    Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for Q4.)

    Time frame: Day 7

  12. Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14

    Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2, the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for question 4.)

    Time frame: Day 14

  13. Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7

    Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better. (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

    Time frame: Day 7

  14. Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14

    Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

    Time frame: Day 14

Secondary outcomes

  1. Summary for Other Questions of PIRS Questionnaire

    The following questions were asked from Section A (Q1 to Q12; 2 Not getting enough sleep, 4 Poor alertness during the daytime, 5 Difficulty keeping your thoughts focused, 6 Others noticing you appeared tired or fatigued, 7 too many difficulties to overcome, 8 Bad moods because you had poor sleep, 9 Lack of energy because of poor sleep, 10 Poor sleep that interferes with your relationships, 11 Being unable to sleep, 12 Being able to do only enough to get by, Section B (Q13 to Q16; 13 From the time you tried to go to sleep, How long did it take to fall asleep on most nights, 14 If you woke during the night, how long did it take to fall back to sleep on most nights,15 Not counting times when you were awake in bed, how many hours of actual sleep did you get during the worst night, 16 On how many days did you have trouble coping because of poor sleep and Section C (Q17 to Q20;, 19 The regularity of your sleep, 20 The soundness of your sleep)

    Time frame: At Day 7 and Day 14

  2. Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime

    Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  3. Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning

    Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  4. Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime

    Participants were asked how open their nose feels before and after strip application at bedtime. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  5. Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.

    Participants were asked how open their nose feels before and after strip removal in morning. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  6. Summary of Daily Diary Questions Before and After Strip Application at Bedtime

    Participants were asked how stuffed their nose felt before and after strip application at bed time. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  7. Summary of Daily Dairy Questions Before and After Strip Removal in Morning

    Participants were asked how stuffed their nose felt before and after strip removal in morning. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

    Time frame: At Day 1, Day 2, day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

  8. Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).

    Participants were asked how breathing felt after nasal strip was applied at bed time and removed in morning. The participants scored their responses on the scale of -5 to 5 where -5 = much worse, 0 = same and 5= much better. These responses were recorded daily.

    Time frame: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day13

  9. Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.

    Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

    Time frame: At Day 7 and at Day 14

  10. Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ

    Participants scored all two domains of NRQLQ using same 7 points scale: 0=Not troubled, 1=Hardly troubled, 3=moderately troubled, 4=quite a bit troubled, 5=very troubled, 6=extremely troubled. Domains were Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score), and Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up); Lower scores indicate improvement in the rhinitis symptoms.

    Time frame: At Day 7 and Day 14

  11. Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)

    Participants were asked Q2 (How stuffed does your nose feel at this time?) and Q4 (How Breathing felt after the nasal strip was applied) of daily diary questions. Q2 was scored on 4 point scale where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms and Q4 on 11 point scale where -5=much worse, 0=same, 5=much better.

    Time frame: on first night (Night 1) of each daily diary question

  12. Number of Participants Showing Improvement for VAS Scale Daily Diary Questions

    Participants were asked following daily diary VAS scale questions a) How easy it was to breathe through your nose and b) How open their nose feels at this time. Both of these questions were scored using 100 mm VAS scale where, 0=extremely difficult, 100=extremely easy.

    Time frame: on first night (Night 1) of each daily diary question

07

Results

Posted Apr 9, 2018

Participant flow

Participants were recruited at two centers in USA.

Participant flow — Overall Study
MilestoneMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Started202120
Completed202120
Not completed000

Outcome measures

PrimaryChange From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7

The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

Time frame:
At Baseline and Day 7
Reported as:
Least squares mean · Score on a scale
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Q1-0.911 (-1.21 to -0.61)-0.694 (-0.99 to -0.40)-1.032 (-1.34 to -0.72)
Q3-1.004 (-1.37 to -0.63)-0.708 (-1.07 to -0.34)-0.947 (-1.33 to -0.56)
Q17-0.721 (-1.01 to -0.43)-0.349 (-0.63 to -0.07)-0.539 (-0.84 to -0.24)
Q18-0.643 (-0.91 to -0.38)-0.234 (-0.50 to 0.03)-0.697 (-0.98 to -0.42)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.5456 (Between treatment p-values and confidence intervals) · Least square (ls) mean difference: -0.12 · 95% CI -0.52 to 0.28
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1029 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.34 · 95% CI -0.75 to 0.07
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2879 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.22 · 95% CI -0.19 to 0.62
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.8213 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.06 · 95% CI -0.45 to 0.56
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.3457 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.24 · 95% CI -0.74 to 0.27
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2364 · Ls mean difference: 0.30 · 95% CI -0.20 to 0.79
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.3553 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.18 · 95% CI -0.21 to 0.57
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.3369 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.19 · 95% CI -0.58 to 0.20
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0591 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.37 · 95% CI -0.01 to 0.76
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.7686 (Between treatment p-values and confidence intervals.) · Ls mean difference: -0.05 · 95% CI -0.42 to 0.31
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0151 · Ls mean difference: -0.46 · 95% CI -0.83 to -0.09
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0256 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.41 · 95% CI 0.05 to 0.77
PrimaryChange From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14

Participant were asked questions related to their sleep using PIRS questionnaire. The PIRS questionnaire had 3 sections. Section A (Q1 to Q12), Section B (Q13 to Q16) and Section C (Q17 to Q20). Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B questions 13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Questions 15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

Time frame:
At Baseline and Day 14
Reported as:
Least squares mean · Score on a scale
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Q1 (One or more awakenings after getting to sleep)-1.047 (-1.36 to -0.74)-0.844 (-1.14 to -0.54)-1.157 (-1.48 to -0.84)
Q3 (Sleep that does not fully refresh you)-1.306 (-1.69 to -0.92)-0.917 (-1.30 to -0.54)-1.104 (-1.50 to -0.70)
Q17 (Your sleep quality compared to most people)-0.714 (-1.04 to -0.39)-0.359 (-0.68 to -0.04)-0.837 (-1.17 to -0.50)
Q18 (Your satisfaction with your sleep)-0.873 (-1.18 to -0.57)-0.464 (-0.76 to -0.16)-0.951 (-1.27 to -0.63)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.5958 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.11 · 95% CI -0.52 to 0.30
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1429 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.31 · 95% CI -0.73 to 0.11
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.3348 · Ls mean difference: 0.20 · 95% CI -0.21 to 0.62
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4425 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.20 · 95% CI -0.32 to 0.72
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4795 · Ls mean difference: -0.19 · 95% CI -0.71 to 0.34
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.1375 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.39 · 95% CI -0.13 to 0.90
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.5750 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.12 · 95% CI -0.56 to 0.31
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0337 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.48 · 95% CI -0.92 to -0.04
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.1061 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.35 · 95% CI -0.08 to 0.79
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.7092 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.08 · 95% CI -0.50 to 0.34
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0250 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.49 · 95% CI -0.91 to -0.06
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0503 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.41 · 95% CI 0.00 to 0.82
PrimaryChange From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers (such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Time frame:
At Baseline and Day 7
Reported as:
Least squares mean · Score on a Scale
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Sleep Problems-7.398 (-9.44 to -5.36)-4.194 (-6.18 to -2.21)-6.563 (-8.71 to -4.42)
Sleep time Problems-7.494 (-9.99 to -5.00)-5.638 (-8.09 to -3.19)-8.212 (-10.81 to -5.61)
Symptoms on walking in the morning-7.196 (-9.28 to -5.11)-4.074 (-6.13 to -2.02)-7.905 (-10.09 to -5.72)
Practical Problems-2.774 (-4.02 to -1.52)-2.277 (-3.51 to -1.04)-3.079 (-4.38 to -1.78)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.5462 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.84 · 95% CI -1.92 to 3.59
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0942 (Between treatment p-values and confidence intervals.) · Ls mean difference: -2.37 · 95% CI -5.16 to 0.42
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0221 (Between treatment p-values and confidence intervals) · Ls mean difference: 3.20 · 95% CI 0.48 to 5.93
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.6731 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.72 · 95% CI -4.11 to 2.68
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1354 (Between treatment p-values and confidence intervals) · Ls mean difference: -2.57 · 95% CI -5.98 to 0.83
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2722 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.86 · 95% CI -1.50 to 5.21
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.6195 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.71 · 95% CI -3.55 to 2.14
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0099 (Between treatment p-values and confidence intervals) · Ls mean difference: -3.83 · 95% CI -6.70 to -0.96
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0298 (Between treatment p-values and confidence intervals) · Ls mean difference: 3.12 · 95% CI 0.32 to 5.93
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.7211 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.30 · 95% CI -2.01 to 1.40
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.3500 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.80 · 95% CI -2.51 to 0.90
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.5564 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.50 · 95% CI -1.19 to 2.18
PrimaryChange From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Time frame:
At Baseline and Day 14
Reported as:
Least squares mean · Score on a scale
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Sleep Problems-7.624 (-9.68 to -5.57)-5.738 (-7.74 to -3.74)-7.051 (-9.21 to -4.89)
Sleep Time Problems-8.746 (-11.24 to -6.26)-7.051 (-9.49 to -4.61)-6.768 (-9.36 to -4.18)
Symptoms on waking in the morning-7.858 (-9.90 to -5.81)-5.318 (-7.33 to -3.30)-8.001 (-10.14 to -5.86)
Practical Problems-3.591 (-4.74 to -2.44)-3.208 (-4.34 to -2.07)-3.054 (-4.25 to -1.86)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.6804 (Between treatment p-values and confidence intervals.) · Ls mean difference: 0.57 · 95% CI -2.20 to 3.35
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.3524 (Between treatment p-values and confidence intervals) · Ls mean difference: -1.31 · 95% CI -4.12 to 1.49
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.1739 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.89 · 95% CI -0.86 to 4.63
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.2463 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.98 · 95% CI -1.41 to 5.36Between treatment p-values and confidence intervals
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.8677 · Ls mean difference: 0.28 · 95% CI -3.11 to 3.68
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.3136 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.70 · 95% CI -1.65 to 5.04
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.9183 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.14 · 95% CI -2.93 to 2.65
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0614 (Between treatment p-values and confidence intervals) · Ls mean difference: -2.68 · 95% CI -5.50 to 0.13
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0695 (Between treatment p-values and confidence intervals) · Ls mean difference: 2.54 · 95% CI -0.21 to 5.29
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4947 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.54 · 95% CI -1.03 to 2.10
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.8454 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.15 · 95% CI -1.42 to 1.72
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.6223 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.38 · 95% CI -1.17 to 1.93
PrimaryChange From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7

Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lower CQ7 scores reflect better nasal patency.

Time frame:
At Baseline and Day 7
Reported as:
Least squares mean · Score on a scale
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7-6.845 (-9.28 to -4.41)-5.137 (-7.53 to -2.74)-8.184 (-10.75 to -5.62)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · LS Mean Difference · p = 0.4258 (Between treatment p-values and confidence intervals) · Ls mean difference: -1.34 · 95% CI -4.68 to 2.01
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0764 (Between treatment p-values and confidence intervals) · Ls mean difference: -3.05 · 95% CI -6.43 to 0.33
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2986 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.71 · 95% CI -1.56 to 4.97
PrimaryChange From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14

Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lowe CQ7 scores reflect better nasal patency.

Time frame:
At Baseline and Day 14
Reported as:
Least squares mean · Score on a Scale
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14-8.035 (-10.34 to -5.73)-5.102 (-7.37 to -2.83)-6.917 (-9.35 to -4.49)
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4820 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.12 · 95% CI -2.05 to 4.29
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.2607 (Between treatment p-values and confidence intervals) · Ls mean difference: -1.81 · 95% CI -5.02 to 1.39
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0623 (Between treatment p-values and confidence intervals) · Ls mean difference: 2.93 · 95% CI -0.16 to 6.02
PrimaryMean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Time frame:
Day 7
Reported as:
Mean · Score on scale
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
Score on scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application32.10 ± 22.38636.37 ± 21.94540.53 ± 18.234
After strip application58.95 ± 28.54347.42 ± 26.74261.11 ± 21.787
Change from Baseline23.25 ± 72.48.75 ± 24.018.89 ± 46.6
Statistical analysis
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.5278 (Between treatment p-values and confidence intervals) · Ls mean difference: -4.36 · 95% CI -18.1 to 9.39
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1458 (Between treatment p-values and confidence intervals) · Ls mean difference: 10.14 · 95% CI -3.64 to 23.93
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0370 (Between treatment p-values and confidence intervals.) · Ls mean difference: -14.50 · 95% CI -28.1 to -0.91
PrimaryMean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Time frame:
Day 14
Reported as:
Mean · Score on a scale
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application39.90 ± 24.07043.21 ± 24.00145.89 ± 22.292
After strip application68.70 ± 26.63651.05 ± 25.38767.56 ± 23.605
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4483 · Ls mean difference: -5.10 · 95% CI -18.5 to 8.29Between treatment p-values and confidence intervals
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0385 · Ls mean difference: 14.28 · 95% CI 0.79 to 27.77Between treatment p-values and confidence intervals
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0046 · Ls mean difference: -19.37 · 95% CI -32.5 to -6.23Between treatment p-values and confidence intervals
PrimaryMean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Time frame:
Day 7
Reported as:
Mean · Score on a Scale
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal60.15 ± 25.52246.95 ± 25.88862.63 ± 19.774
After strip removal43.10 ± 21.71144.74 ± 25.23660.00 ± 21.654
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0029 (Between treatment p-values and confidence intervals) · Ls mean difference: 15.24 · 95% CI 5.45 to 25.02
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4683 (Between treatment p-values and confidence intervals) · Ls mean difference: 3.74 · 95% CI -6.53 to 14.01
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0259 (Between treatment p-values and confidence intervals) · Ls mean difference: 11.50 · 95% CI 1.44 to 21.55
PrimaryMean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0=extremely difficult to breathe and 100=extremely easy

Time frame:
Day 14
Reported as:
Mean · Score on a scale
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before Strip Removal67.80 ± 24.81648.95 ± 26.51170.61 ± 22.078
After Strip Removal51.35 ± 25.20345.26 ± 25.47361.11 ± 21.978
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1764 (Between treatment p-values and confidence intervals) · Ls mean difference: 7.79 · 95% CI -3.62 to 19.19
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.9183 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.63 · 95% CI -11.7 to 12.94
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2313 (Between treatment p-values and confidence intervals) · Ls mean difference: 7.16 · 95% CI -4.70 to 19.01
PrimaryMean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for Q4.)

Time frame:
Day 7
Reported as:
Mean · Score on a Scale
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application (Q2)1.75 ± 0.5501.70 ± 0.7331.63 ± 0.597
After strip application (Q2)1.00 ± 0.7951.55 ± 0.8871.16 ± 0.688
After strip application (Q4)2.80 ± 1.3991.20 ± 1.4731.79 ± 1.475
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1345 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.27 · 95% CI -0.09 to 0.63
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0815 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.32 · 95% CI -0.68 to 0.04
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0015 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.59 · 95% CI 0.24 to 0.94
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0292 (Between treatment p-values and confidence intervals) · Ls mean differnence: -1.03 · 95% CI -1.96 to -0.11
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.2497 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.54 · 95% CI -0.39 to 1.47
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0011 (Between treatment p-values and confidence intervals) · Ls mean difference: -1.57 · 95% CI -2.48 to -0.66
PrimaryMean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2, the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for question 4.)

Time frame:
Day 14
Reported as:
Mean · Score on a scale
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application (Q2)1.40 ± 0.5981.58 ± 0.6071.61 ± 0.698
After strip application (Q2)0.85 ± 0.8751.35 ± 0.7861.06 ± 0.873
After strip application (Q4)2.70 ± 1.6580.89 ± 1.4102.00 ± 1.715
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.8063 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.06 · 95% CI -0.40 to 0.51
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1356 (Between treatment p-values and confidence intervals) · Ls mean differnence: -0.35 · 95% CI -0.82 to 0.11
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0786 · Ls mean difference: 0.41 · 95% CI -0.05 to 0.87
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1693 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.72 · 95% CI -1.75 to 0.32
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0438 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.08 · 95% CI 0.03 to 2.13
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.0009 (Between treatment p-values and confidence intervals) · Ls mean difference: -1.80 · 95% CI -2.82 to -0.78
PrimaryMean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better. (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

Time frame:
Day 7
Reported as:
Mean · Score on a scale
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal (Q2)1.00 ± 0.6491.60 ± 0.9951.00 ± 0.745
After strip removal (Q2)1.35 ± 0.6711.75 ± 0.9671.11 ± 0.809
After strip removal (Q4)-0.20 ± 2.1180.60 ± 1.7591.16 ± 2.007
Statistical analysis
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.1991 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.24 · 95% CI -0.62 to 0.13
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.2964 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.21 · 95% CI -0.60 to 0.19
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.8495 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.04 · 95% CI -0.42 to 0.35
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0381 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.35 · 95% CI 0.08 to 2.62
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.4005 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.54 · 95% CI -0.74 to 1.82
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.2020 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.81 · 95% CI -0.45 to 2.07
PrimaryMean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

Time frame:
Day 14
Reported as:
Mean · Score ona scale
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
Score ona scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal (Q2)0.95 ± 0.8261.40 ± 0.9400.89 ± 0.832
After strip removal (Q2)1.30 ± 0.6571.45 ± 0.8871.17 ± 0.707
After strip removal (Q4)-0.45 ± 2.2820.60 ± 1.5360.94 ± 2.261
Statistical analysis
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.5741 (Between treatment p-values and confidence intervals) · Ls mean difference: -0.09 · 95% CI -0.41 to 0.23
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.6935 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.06 · 95% CI -0.26 to 0.39
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.3330 (Between treatment p-values and confidence intervals.) · Ls mean difference: -0.15 · 95% CI -0.47 to 0.16
  • Marketed Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.0434 (Between treatment p-values and confidence intervals) · Ls mean difference: 1.39 · 95% CI 0.04 to 2.73
  • Placebo Nasal Strip vs Prototype Nasal Strip · ANCOVA · p = 0.6333 (Between treatment p-values and confidence intervals) · Ls mean difference: 0.32 · 95% CI -1.02 to 1.67
  • Marketed Nasal Strip vs Placebo Nasal Strip · ANCOVA · p = 0.1091 (Between treatment p-values and confidence intervals.) · Ls mean difference: 1.06 · 95% CI -0.25 to 2.37
SecondarySummary for Other Questions of PIRS Questionnaire

The following questions were asked from Section A (Q1 to Q12; 2 Not getting enough sleep, 4 Poor alertness during the daytime, 5 Difficulty keeping your thoughts focused, 6 Others noticing you appeared tired or fatigued, 7 too many difficulties to overcome, 8 Bad moods because you had poor sleep, 9 Lack of energy because of poor sleep, 10 Poor sleep that interferes with your relationships, 11 Being unable to sleep, 12 Being able to do only enough to get by, Section B (Q13 to Q16; 13 From the time you tried to go to sleep, How long did it take to fall asleep on most nights, 14 If you woke during the night, how long did it take to fall back to sleep on most nights,15 Not counting times when you were awake in bed, how many hours of actual sleep did you get during the worst night, 16 On how many days did you have trouble coping because of poor sleep and Section C (Q17 to Q20;, 19 The regularity of your sleep, 20 The soundness of your sleep)

Time frame:
At Day 7 and Day 14
Reported as:
Mean · Score on a Scale
Summary for Other Questions of PIRS Questionnaire
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Q2 (Day 7)1.20 ± 0.8941.40 ± 0.8831.37 ± 0.831
Q2 (Day 14)0.90 ± 0.7881.20 ± 0.8340.95 ± 0.705
Q4 (Day7)0.75 ± 0.7861.05 ± 0.9450.84 ± 0.834
Q4 (Day 14)0.65 ± 0.7450.90 ± 0.7880.63 ± 0.684
Q5 (Day 7)0.65 ± 0.6710.85 ± 0.8130.63 ± 0.684
Q5 (Day 14)0.55 ± 0.6050.65 ± 0.8130.63 ± 0.597
Q6 (Day 7)0.50 ± 0.8270.70 ± 0.9230.68 ± 0.820
Q6 (Day 14)0.50 ± 0.7610.60 ± 0.7540.58 ± 0.692
Q7 (Day 7)0.45 ± 0.6860.60 ± 0.8830.37 ± 0.597
Q7 (Day 14)0.45 ± 0.8260.40 ± 0.6810.32 ± 0.478
Q8 (Day 7)0.65 ± 0.8130.80 ± 0.8940.63 ± 0.684
Q8 (Day 14)0.65 ± 0.7450.55 ± 0.6860.37 ± 0.597
Q9 (Day 7)0.95 ± 0.8261.40 ± 0.9950.89 ± 0.658
Q9 (Day 14)0.80 ± 0.8340.85 ± 0.8130.68 ± 0.749
Q10 (Day 7)0.60 ± 0.8830.60 ± 0.9400.37 ± 0.597
Q10 (Day 14)0.40 ± 0.7540.55 ± 0.8870.37 ± 0.597
Q11 (Day 7)0.70 ± 0.8011.30 ± 0.9791.00 ± 0.745
Q11 (Day 14)0.70 ± 0.8651.05 ± 0.8870.68 ± 0.749
Q12 (Day 7)0.40 ± 0.7540.70 ± 0.7330.63 ± 0.761
Q12 (Day 14)0.30 ± 0.7330.60 ± 0.8210.32 ± 0.582
Q13 (Day 7)0.45 ± 0.6050.70 ± 0.7330.74 ± 0.733
Q13 (Day 14)0.55 ± 0.6050.60 ± 0.7540.63 ± 0.761
Q14 (Day 7)0.35 ± 0.4890.65 ± 0.7450.53 ± 0.697
Q14 (Day 14)0.45 ± 0.6050.55 ± 0.6050.53 ± 0.612
Q15 (Day 7)1.00 ± 0.3241.20 ± 0.6161.32 ± 0.582
Q15 (Day 14)1.05 ± 0.3941.05 ± 0.5101.05 ± 0.621
Q16 (Day 7)0.40 ± 0.7540.74 ± 0.9330.47 ± 0.697
Q16 (Day 14)0.25 ± 0.7160.50 ± 0.6880.32 ± 0.582
Q 19 (Day 7)1.40 ± 0.7542.00 ± 0.7951.68 ± 0.671
Q19 (Day 14)1.35 ± 0.5871.70 ± 0.8651.26 ± 0.733
Q20 (Day 7)1.30 ± 0.9231.85 ± 0.9331.63 ± 0.684
Q20 (Day 14)1.40 ± 0.8211.75 ± 0.9671.21 ± 0.713
SecondarySummary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a scale
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application (Day 1)27.85 ± 20.58234.58 ± 15.79834.00 ± 14.821
After strip application (Day 1)61.55 ± 26.71643.11 ± 24.07155.00 ± 24.866
Before strip application (Day 2)28.2 ± 20.1837.2 ± 23.1842.7 ± 19.26
After strip application (Day 2)60.1 ± 26.1645.2 ± 25.0460.7 ± 22.36
Before strip application (Day 3)29.35 ± 20.29637.95 ± 19.84245.11 ± 23.870
After strip application (Day 3)58.90 ± 26.63848.53 ± 20.66561.42 ± 24.739
Before strip application (Day 4)32.8 ± 20.8733.3 ± 14.2736.4 ± 19.29
After Strip application (Day 4)60.8 ± 28.8645.7 ± 17.8960.2 ± 22.14
Before strip application (Day 5)33.2 ± 23.4536.9 ± 19.7841.4 ± 21.85
After strip application (Day 5)64.9 ± 28.1147.5 ± 22.5163.8 ± 23.95
Before strip application (Day 6)28.6 ± 22.4735.9 ± 20.2944.9 ± 18.55
After strip application (Day 6)60.5 ± 30.0644.8 ± 21.2864.3 ± 20.03
Before strip application (Day 8)35.4 ± 22.0838.6 ± 21.3845.5 ± 19.18
After strip application (Day 8)61.2 ± 26.4147.8 ± 25.0765.0 ± 22.96
Before strip application (Day 9)32.7 ± 24.1140.0 ± 21.1845.6 ± 19.90
After strip application (Day 9)61.2 ± 27.9048.6 ± 24.4563.4 ± 22.45
Before strip application (Day 10)36.9 ± 25.8042.7 ± 27.7140.6 ± 19.74
After strip application (Day 10)68.3 ± 27.7650.2 ± 30.1560.9 ± 24.91
After strip application (Day 11)66.3 ± 26.4549.8 ± 25.1863.2 ± 25.60
Before strip application (Day 11)33.6 ± 25.3340.2 ± 22.9942.1 ± 21.52
Before strip application (Day 12)32.7 ± 25.7942.5 ± 24.9647.5 ± 21.51
After strip application (Day 12)66.8 ± 27.4352.8 ± 26.4665.7 ± 23.44
Before strip application (Day 13)33.9 ± 27.2843.5 ± 23.0748.1 ± 24.12
After strip application (Day 13)66.7 ± 26.6253.1 ± 26.1667.8 ± 24.38
SecondarySummary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a scale
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal (Day 1)54.60 ± 30.40745.11 ± 22.58860.44 ± 20.024
After strip removal (Day 1)44.75 ± 21.56041.47 ± 20.01851.44 ± 20.569
Before strip removal (Day 2)61.0 ± 26.2544.1 ± 22.5660.0 ± 22.85
After strip removal (Day 2)46.8 ± 21.8042.1 ± 22.3451.2 ± 21.76
Before strip removal (Day 3)63.60 ± 27.58248.37 ± 23.86460.21 ± 24.114
After strip removal (Day 3)44.90 ± 21.07145.53 ± 23.23656.79 ± 21.578
Before strip removal (Day 4)64.9 ± 26.3550.0 ± 19.0662.8 ± 21.56
After strip removal (Day 4)49.2 ± 23.3745.9 ± 21.2753.6 ± 20.99
Before strip removal (Day 5)65.0 ± 27.4847.4 ± 21.9464.0 ± 20.90
After strip removal (Day 5)49.7 ± 23.5043.4 ± 23.2158.1 ± 19.31
Before strip removal (Day 6)60.9 ± 27.3446.2 ± 23.9463.1 ± 21.40
After strip removal (Day 6)47.0 ± 24.0342.4 ± 23.1658.6 ± 18.40
Before strip removal (Day 8)64.7 ± 25.3443.6 ± 25.5565.2 ± 20.39
After strip removal (Day 8)46.6 ± 25.5040.7 ± 24.0760.4 ± 19.35
Before strip removal (Day 9)61.1 ± 27.8246.7 ± 24.6865.1 ± 23.06
After strip removal (Day 9)49.0 ± 26.3441.7 ± 24.0859.5 ± 20.19
Before strip removal (Day 10)66.2 ± 25.8545.6 ± 26.8865.4 ± 22.52
After strip removal (Day 10)50.6 ± 24.9242.4 ± 26.5757.5 ± 22.10
Before strip removal (Day 11)62.3 ± 26.3747.3 ± 25.7967.5 ± 20.50
After strip removal (Day 11)46.4 ± 23.9342.2 ± 23.9857.0 ± 19.91
Before strip removal (Day 12)63.8 ± 25.5849.2 ± 24.9567.6 ± 21.03
After strip removal (Day 12)48.7 ± 27.3946.3 ± 23.4559.4 ± 21.30
Before strip removal (Day 13)64.3 ± 25.5846.4 ± 26.1868.4 ± 22.84
After strip removal (Day 13)46.6 ± 27.3943.3 ± 26.3760.0 ± 21.02
SecondarySummary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime

Participants were asked how open their nose feels before and after strip application at bedtime. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a Scale
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application (Day 1)27.90 ± 20.46337.74 ± 17.14335.89 ± 14.644
After strip application (Day 1)61.45 ± 25.85345.84 ± 23.06157.68 ± 22.583
Before strip application (Day 2)27.5 ± 19.6438.3 ± 22.1742.2 ± 19.49
After strip application (Day 2)59.8 ± 26.9047.0 ± 24.1063.2 ± 63.2
Before strip application (Day 3)30.05 ± 20.40538.32 ± 19.28546.42 ± 24.132
After strip application (Day 3)59.25 ± 27.46649.74 ± 22.09862.16 ± 24.847
Before strip application (Day 4)32.6 ± 20.5133.6 ± 14.7836.6 ± 18.74
After strip application (Day 4)60.5 ± 28.3146.7 ± 17.3461.1 ± 23.41
Before strip application (Day 5)33.4 ± 23.8536.1 ± 19.5742.1 ± 21.60
After strip appliation (Day 5)65.6 ± 28.4449.3 ± 22.6266.7 ± 23.97
Before strip application (Day 6)26.7 ± 20.5835.3 ± 18.5944.8 ± 20.14
After strip application (Day 6)60.5 ± 28.8643.9 ± 19.3466.5 ± 20.92
Before strip application (Day 8)33.9 ± 21.1537.9 ± 22.5446.9 ± 20.76
After strip application (Day 8)63.4 ± 26.9446.5 ± 24.7467.5 ± 67.5
Before strip application (Day 9)32.7 ± 24.4237.6 ± 20.7045.8 ± 21.77
After strip application (Day 9)65.6 ± 26.7149.5 ± 25.3465.5 ± 23.09
Before strip application (Day 10)36.2 ± 42.142.1 ± 26.9441.8 ± 22.31
After strip application (Day 10)68.7 ± 26.8552.1 ± 30.4563.0 ± 25.34
Before strip application (Day 11)35.4 ± 24.7941.3 ± 23.7441.3 ± 22.54
After strip application (Day 11)67.3 ± 26.6950.5 ± 27.0264.8 ± 25.15
Before strip application (Day 12)34.7 ± 26.7144.2 ± 24.7847.5 ± 23.30
After strip application (Day 12)68.4 ± 26.6753.4 ± 26.4067.5 ± 23.95
Before strip application (Day 13)34.9 ± 26.3642.7 ± 23.5850.3 ± 24.75
After strip application (Day 13)67.1 ± 25.9053.6 ± 25.7468.1 ± 25.28
SecondarySummary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.

Participants were asked how open their nose feels before and after strip removal in morning. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a Scale
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Score on a ScaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal (Day 1)53.95 ± 29.88345.37 ± 25.04960.22 ± 21.198
After strip removal (Day 1)44.70 ± 22.18142.53 ± 20.29151.56 ± 22.727
Before strip removal (Day 2)60.8 ± 26.4643.7 ± 20.8560.6 ± 23.48
After strip removal (Day 2)45.7 ± 23.5643.4 ± 22.5653.1 ± 22.81
Before strip removal (Day 3)61.35 ± 27.87146.89 ± 23.81260.53 ± 24.688
After strip removal (Day 3)44.30 ± 21.44045.47 ± 22.47358.11 ± 22.652
Before strip removal (Day 4)63.7 ± 25.5148.2 ± 19.2364.7 ± 22.55
After strip removal (Day 4)48.3 ± 22.1045.5 ± 21.1855.1 ± 21.13
Before strip removal (Day 5)65.2 ± 27.6645.2 ± 23.7464.4 ± 20.52
After strip removal (Day 5)49.3 ± 25.0843.4 ± 23.3059.6 ± 20.14
Before strip removal (Day 6)60.4 ± 27.2545.9 ± 24.3464.9 ± 22.29
After strip removal (Day 6)45.0 ± 22.7445.6 ± 22.7758.8 ± 19.74
Before strip removal (Day 8)65.3 ± 25.6541.6 ± 25.5466.7 ± 21.14
After strip removal (Day 8)46.9 ± 26.8242.5 ± 24.6259.7 ± 19.85
Before strip removal (Day 9)62.8 ± 25.8643.3 ± 24.4165.5 ± 21.99
After strip removal (Day 9)48.3 ± 27.5540.1 ± 24.9860.2 ± 20.34
Before strip removal (Day 10)66.1 ± 25.6743.1 ± 26.5267.1 ± 23.01
After strip removal (Day 10)50.6 ± 25.4342.7 ± 26.5557.6 ± 22.72
Before strip removal (Day 11)61.6 ± 26.5444.3 ± 25.6767.2 ± 21.63
After strip removal (Day 11)47.1 ± 23.9242.2 ± 24.5424.54 ± 20.87
Before strip removal (Day 12)63.1 ± 26.1246.5 ± 23.7269.2 ± 20.81
After strip removal (Day 12)49.7 ± 27.5247.4 ± 21.7261.8 ± 22.26
Before strip removal (Day 13)64.9 ± 25.4140.9 ± 24.8368.6 ± 22.41
After strip removal (Day 13)46.4 ± 28.2442.3 ± 24.8561.0 ± 22.33
SecondarySummary of Daily Diary Questions Before and After Strip Application at Bedtime

Participants were asked how stuffed their nose felt before and after strip application at bed time. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a scale
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip application (Day 1)1.95 ± 0.3942.00 ± 0.5621.79 ± 0.535
After strip application (Day 1)1.10 ± 0.7881.80 ± 0.6961.26 ± 0.562
Before strip application (Day 2)1.80 ± 0.6961.85 ± 0.5871.53 ± 0.612
After strip application (Day 2)1.05 ± 0.6861.70 ± 0.7331.11 ± 0.658
Before strip application (Day 3)1.90 ± 0.6411.90 ± 0.5531.58 ± 0.692
After strip application (Day 3)1.16 ± 0.8981.60 ± 0.7541.16 ± 0.688
Before strip application (Day 4)1.55 ± 0.6861.70 ± 0.7331.74 ± 0.562
After strip application (Day 4)0.95 ± 0.8871.55 ± 0.7591.16 ± 0.602
Before strip application (Day 5)1.75 ± 0.5501.65 ± 0.6711.53 ± 0.772
After strip application (Day 5)1.00 ± 0.7951.50 ± 0.7611.21 ± 0.855
Before strip application (Day 6)1.90 ± 0.6411.75 ± 0.7161.53 ± 0.697
After strip application (Day 6)1.00 ± 0.7951.65 ± 0.8131.16 ± 0.501
Before strip application (Day 8)1.70 ± 0.5711.70 ± 0.5711.47 ± 0.513
After strip application (Day 8)1.15 ± 0.8131.47 ± 0.7720.83 ± 0.786
Before strip application (Day 9)1.70 ± 0.5711.58 ± 0.8381.39 ± 0.608
After strip application (Day 9)1.05 ± 0.8261.37 ± 0.9551.05 ± 0.705
Before strip application (Day 10)1.60 ± 0.5981.65 ± 0.9331.37 ± 0.831
After strip application (Day 10)0.95 ± 0.9451.50 ± 1.0511.21 ± 0.918
Before strip application (Day 11)1.68 ± 0.6711.60 ± 0.8211.56 ± 0.616
After strip application (Day 11)1.15 ± 0.8751.45 ± 0.9451.11 ± 0.676
Before strip application (Day 12)1.74 ± 0.6531.40 ± 0.7541.37 ± 0.684
After strip application (Day 12)1.05 ± 0.9111.26 ± 0.8720.95 ± 0.621
Before strip application (Day 13)1.75 ± 0.6391.50 ± 0.6881.39 ± 0.850
After strip applications (Day 13)0.90 ± 0.9121.35 ± 0.8131.05 ± 0.848
SecondarySummary of Daily Dairy Questions Before and After Strip Removal in Morning

Participants were asked how stuffed their nose felt before and after strip removal in morning. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

Time frame:
At Day 1, Day 2, day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13
Reported as:
Mean · Score on a scale
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Before strip removal (Day 1)1.15 ± 0.7451.55 ± 0.7591.22 ± 0.647
After strip removal (Day 1)1.35 ± 0.6711.65 ± 0.7451.33 ± 0.594
Before strip removal (Day 2)1.05 ± 0.6861.53 ± 0.9051.21 ± 0.855
After strip removal (Day 2)1.40 ± 0.6811.70 ± 0.8011.32 ± 0.671
Before strip removal (Day 3)0.84 ± 0.6881.45 ± 0.8871.11 ± 0.737
After strip removal (Day 3)1.35 ± 0.6711.55 ± 0.8261.11 ± 0.583
Before strip removal (Day 4)0.95 ± 0.8261.42 ± 0.8381.00 ± 0.816
After strip removal (Day 4)1.25 ± 0.6391.55 ± 0.7591.11 ± 0.658
Before strip removal (Day 5)0.95 ± 0.7591.40 ± 0.8211.00 ± 0.882
After strip removal (Day 5)1.25 ± 0.7861.55 ± 0.8260.95 ± 0.621
Before strip removal (Day 6)1.05 ± 0.8261.55 ± 0.9991.00 ± 0.816
After strip removal (Day 6)1.40 ± 0.7541.65 ± 0.9331.05 ± 0.621
Before strip removal (Day 8)1.05 ± 0.7591.55 ± 0.9450.84 ± 0.688
After strip removal (Day 8)1.45 ± 0.8261.68 ± 0.8851.00 ± 0.745
Before strip removal (Day 9)0.95 ± 0.8261.45 ± 1.0500.79 ± 0.631
After strip removal (Day 9)1.45 ± 0.8261.58 ± 1.0170.95 ± 0.621
Before strip removal (Day 10)0.90 ± 0.8521.60 ± 0.9951.00 ± 0.767
After strip removal (Day 10)1.20 ± 0.7681.60 ± 0.9401.21 ± 0.713
Before strip removal (Day 11)1.20 ± 0.8341.55 ± 0.9451.00 ± 0.577
After strip removal (Day 11)1.50 ± 0.7611.70 ± 0.9231.21 ± 0.631
Before strip removal (Day 12)1.00 ± 0.8821.30 ± 1.0310.74 ± 0.733
After strip removal (Day 12)1.37 ± 0.8311.40 ± 0.9950.95 ± 0.621
Before strip removal (Day 13)0.95 ± 0.8261.50 ± 1.0001.00 ± 0.745
After strip removal (Day 13)1.40 ± 0.8831.65 ± 0.9331.05 ± 0.848
SecondarySummary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).

Participants were asked how breathing felt after nasal strip was applied at bed time and removed in morning. The participants scored their responses on the scale of -5 to 5 where -5 = much worse, 0 = same and 5= much better. These responses were recorded daily.

Time frame:
At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day13
Reported as:
Mean · Score on a scale
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
After strip application (Day 1)2.45 ± 1.3951.20 ± 1.4731.42 ± 2.116
After strip removal (Day 1)-0.30 ± 2.0550.25 ± 1.6500.50 ± 2.407
After strip application (Day 2)1.95 ± 1.9320.90 ± 1.4101.53 ± 1.744
After strip removal (Day 2)-0.10 ± 2.0750.30 ± 1.5250.26 ± 2.182
After strip application (Day 3)2.40 ± 1.6671.20 ± 1.3611.74 ± 1.727
After strip removal (Day 3)-0.35 ± 2.1830.85 ± 1.6310.68 ± 1.734
After strip application (Day 4)2.70 ± 1.5251.10 ± 1.3341.47 ± 1.896
After strip removal (Day 4)-0.50 ± 2.1150.45 ± 1.7310.47 ± 2.118
After strip application (Day 5)2.80 ± 1.7651.05 ± 1.6051.63 ± 1.707
After strip removal (Day 5)-0.20 ± 2.3970.55 ± 1.7310.84 ± 2.167
After strip application (Day 6)2.85 ± 1.5650.95 ± 1.5041.89 ± 1.629
After strip removal (Day 6)-0.45 ± 2.2820.50 ± 1.7920.74 ± 2.077
After strip application (Day 8)2.65 ± 1.7550.85 ± 1.3091.84 ± 1.864
After strip removal (Day 8)-0.45 ± 2.1640.25 ± 1.1640.79 ± 2.043
After strip application (Day 9)2.80 ± 1.5760.84 ± 1.3441.84 ± 1.675
After strip removal (Day 9)-0.40 ± 2.4150.20 ± 1.1961.00 ± 1.856
After strip application (Day 10)2.85 ± 1.5990.95 ± 1.2341.95 ± 1.580
After strip removal (Day 10)-0.47 ± 2.4120.25 ± 1.2511.00 ± 2.082
After strip application (Day 11)2.60 ± 1.7590.75 ± 1.2931.84 ± 1.675
After strip removal (Day 11)-0.65 ± 2.2770.10 ± 1.4100.68 ± 2.056
After strip application (Day 12)2.79 ± 1.7820.95 ± 1.3172.00 ± 1.491
After strip removal (Day 12)-0.74 ± 2.3060.30 ± 1.2180.89 ± 2.052
After strip application (Day 13)2.65 ± 1.6310.95 ± 1.3172.05 ± 1.649
After strip removal (Day 13)-0.40 ± 2.7030.35 ± 1.4240.79 ± 1.988
SecondaryChange From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Time frame:
At Day 7 and at Day 14
Reported as:
Mean · Score on a scale
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Score on a scaleMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Sleep Problems (Day 7)7.62 ± 6.11711.58 ± 7.4526.09 ± 4.826
Sleep Problems (Day 14)6.92 ± 5.9519.75 ± 6.7714.91 ± 4.134
Sleep time problems (Day 7)7.62 ± 6.83810.08 ± 7.4896.00 ± 7.225
Sleep time problems (Day 14)6.77 ± 7.6838.50 ± 8.7136.18 ± 7.054
Symptoms on waking in morning (Day 7)8.69 ± 6.70112.00 ± 5.6735.45 ± 4.228
Symptoms on waking in morning (Day 14)8.31 ± 5.93610.42 ± 6.5435.00 ± 4.472
Practical problems (Day 7)3.00 ± 5.0334.67 ± 3.6012.55 ± 3.503
Practical Problems (Day 14)2.54 ± 4.8583.08 ± 3.0592.64 ± 2.942
SecondaryNumber of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ

Participants scored all two domains of NRQLQ using same 7 points scale: 0=Not troubled, 1=Hardly troubled, 3=moderately troubled, 4=quite a bit troubled, 5=very troubled, 6=extremely troubled. Domains were Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score), and Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up); Lower scores indicate improvement in the rhinitis symptoms.

Time frame:
At Day 7 and Day 14
Reported as:
Count of participants · Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
ParticipantsMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
All sleep problems (Day 7)14511
All sleep problems (Day 14)121013
Any sleep problems (Day 7)181819
Any sleep problems (Day 14)201917
All symptoms on waking (Day 7)141114
All symptoms on waking (Day 14)141116
Any symptoms on waking (Day 7)191719
Any symptoms on waking (Day 14)191819
SecondaryNumber of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)

Participants were asked Q2 (How stuffed does your nose feel at this time?) and Q4 (How Breathing felt after the nasal strip was applied) of daily diary questions. Q2 was scored on 4 point scale where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms and Q4 on 11 point scale where -5=much worse, 0=same, 5=much better.

Time frame:
on first night (Night 1) of each daily diary question
Reported as:
Count of participants · Participants
Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)
ParticipantsMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Q213310
Q4181112
SecondaryNumber of Participants Showing Improvement for VAS Scale Daily Diary Questions

Participants were asked following daily diary VAS scale questions a) How easy it was to breathe through your nose and b) How open their nose feels at this time. Both of these questions were scored using 100 mm VAS scale where, 0=extremely difficult, 100=extremely easy.

Time frame:
on first night (Night 1) of each daily diary question
Reported as:
Count of participants · Participants
Number of Participants Showing Improvement for VAS Scale Daily Diary Questions
ParticipantsMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Strip
Easy to breathe201115
Openness191313

Adverse events

Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Marketed Nasal Strip0/20 (0%)0/20 (0%)0/20 (0%)
Placebo Nasal Strip0/21 (0%)0/21 (0%)1/21 (4.8%)
Prototype Nasal Dilator0/19 (0%)0/19 (0%)0/19 (0%)
Most frequent other events
Most frequent other events
EventMarketed Nasal StripPlacebo Nasal StripPrototype Nasal Dilator
Nasal scab secondary to strip removalGeneral disorders0/201/210/19

Baseline characteristics

Age, Customized
Age, Customized(Years)Marketed Nasal StripPlacebo Nasal StripPrototype Nasal StripTotal
Years46.1 ± 10.1744.5 ± 9.5942.5 ± 13.9744.4 ± 11.29
Sex: Female, Male
Sex: Female, Male(Participants)Marketed Nasal StripPlacebo Nasal StripPrototype Nasal StripTotal
Female18171550
Male24511
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Marketed Nasal StripPlacebo Nasal StripPrototype Nasal StripTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White20212061
More than one race0000
Unknown or Not Reported0000
08

Study locations

2 sites
  • TKL Research Inc
    Paramus, New Jersey 07652, United States
  • Valley Clinical Research Center
    Bethlehem, Pennsylvania 18020, United States
09

References and documents

Publications

  • Schenkel EJ, Ciesla R, Shanga GM. Effects of nasal dilator strips on subjective measures of sleep in subjects with chronic nocturnal nasal congestion: a randomized, placebo-controlled trial. Allergy Asthma Clin Immunol. 2018 Aug 27;14:34. doi: 10.1186/s13223-018-0258-5. eCollection 2018. PubMed 30154874 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01122849
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
May 13, 2010
Start date
Oct 1, 2009
Primary completion
Feb 1, 2010
Completion
Feb 1, 2010
Results posted
Apr 9, 2018
Last update
Apr 9, 2018

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion